RankingsPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Dividend per share

KYORIN Pharmaceutical Co., Ltd.【JP:4569】

Market cap
¥105.3B
P/E ratio
19.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndDividend per share (JPY)YoY (%)
Mar 31, 202557+9.62%
Mar 31, 202452+0.00%
Mar 31, 202352+0.00%
Mar 31, 202252-30.67%
Mar 31, 202175+0.00%
Mar 31, 202075+0.00%
Mar 31, 201975+29.31%
Mar 31, 201858+0.00%
Mar 31, 201758+0.00%
Mar 31, 201658+11.54%
Mar 31, 201552+0.00%
Mar 31, 201452+4.00%
Mar 31, 201350+11.11%
Mar 31, 201245

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)